Institut de Développement Industriel SCA

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: FR0000051393
EUR
68.00
0.6 (0.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Institut de Développement Industriel SCA stock-summary
stock-summary
Institut de Développement Industriel SCA
Capital Markets
IDI SCA is a France-based investment operator that is active in the French private equity market. The Company specializes in capital investments in France, such as leveraged acquisitions and private investments in public equity (PIPE), as well as mezzanine financing. It is also active in the purchase of secondary market portfolios and, abroad, the investments in emerging markets, as well as in the management of hedge funds, long short funds, among others. As of December 31, 2011, the Company operated through subsidiaries, including Domosys Finance, IDI Emerging Markets, Idinvest Partners and Domaine Romaneira, among others. In June, 2013, it sold its stake in Groupe Sorgem. In February 2014, it acquired the majority stake in WINNCARE, a French designer and manufacturer of bed systems and anti-bedsore mattresses.
Company Coordinates stock-summary
Company Details
18 avenue Matignon , PARIS None : 75008
stock-summary
Tel: 33 1 5527800033 1 55278000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mrs. Luce Gendry
Non-Executive Independent Chairman of the Supervisory Board
Mr. Sebastien Coquard
Non-Executive Independent Vice Chairman of the Supervisory Board
Mr. Philippe Charquet
Non-Executive Member of the Supervisory Board
Mr. Aimery Langlois-Meurinne
Non-Executive Member of the Supervisory Board
Ms. Iris Langlois-Meurinne
Non-Executive Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Sep 2012)
Net Profit:
stock-summary
Industry

Capital Markets

stock-summary
Market cap

EUR 492 Million ()

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.50%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

2.83%

stock-summary
Price to Book

0.71